StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a report released on Sunday. The firm set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Price Performance
CO stock opened at $1.25 on Friday. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50. The stock’s 50 day moving average is $1.46 and its two-hundred day moving average is $1.36. The company has a market capitalization of $151.94 million, a PE ratio of 1.95 and a beta of 0.16.
About Global Cord Blood
Featured Articles
- Five stocks we like better than Global Cord Blood
- Health Care Stocks Explained: Why You Might Want to Invest
- MarketBeat Week in Review – 4/22 – 4/26
- What Are Growth Stocks and Investing in Them
- 3 Stocks Leading the U.S. Agriculture Comeback
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.